IL134597A0 - Therapy for staphylococcus aureus - Google Patents

Therapy for staphylococcus aureus

Info

Publication number
IL134597A0
IL134597A0 IL13459798A IL13459798A IL134597A0 IL 134597 A0 IL134597 A0 IL 134597A0 IL 13459798 A IL13459798 A IL 13459798A IL 13459798 A IL13459798 A IL 13459798A IL 134597 A0 IL134597 A0 IL 134597A0
Authority
IL
Israel
Prior art keywords
staphylococcus aureus
therapy
strains
strain
directed
Prior art date
Application number
IL13459798A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL134597A0 publication Critical patent/IL134597A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL13459798A 1997-08-22 1998-08-18 Therapy for staphylococcus aureus IL134597A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5671297P 1997-08-22 1997-08-22
PCT/US1998/017138 WO1999010006A1 (en) 1997-08-22 1998-08-18 Therapy for staphylococcus aureus

Publications (1)

Publication Number Publication Date
IL134597A0 true IL134597A0 (en) 2001-04-30

Family

ID=22006150

Family Applications (2)

Application Number Title Priority Date Filing Date
IL13459798A IL134597A0 (en) 1997-08-22 1998-08-18 Therapy for staphylococcus aureus
IL134597A IL134597A (en) 1997-08-22 2000-02-17 Use of an antibiotic compound for the preparation of a drug for the treatment of diseases that can be attributed to Staphylococcus aureus

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL134597A IL134597A (en) 1997-08-22 2000-02-17 Use of an antibiotic compound for the preparation of a drug for the treatment of diseases that can be attributed to Staphylococcus aureus

Country Status (23)

Country Link
US (1) US5994297A (xx)
EP (1) EP0897725B1 (xx)
JP (1) JP2001513573A (xx)
KR (1) KR100589548B1 (xx)
CN (1) CN1276728A (xx)
AT (1) ATE278413T1 (xx)
AU (1) AU747418B2 (xx)
BR (1) BR9811917A (xx)
CA (1) CA2301589A1 (xx)
CZ (1) CZ299098B6 (xx)
DE (1) DE69826795T2 (xx)
DK (1) DK0897725T3 (xx)
EA (1) EA002602B1 (xx)
ES (1) ES2229454T3 (xx)
HU (1) HU226593B1 (xx)
ID (1) ID24908A (xx)
IL (2) IL134597A0 (xx)
NO (1) NO327042B1 (xx)
NZ (1) NZ502762A (xx)
PT (1) PT897725E (xx)
TR (1) TR200000475T2 (xx)
UA (1) UA59410C2 (xx)
WO (1) WO1999010006A1 (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA020490B1 (ru) * 2008-08-30 2014-11-28 Тарганта Терапьютикс Корп. Способ лечения бактериальной инфекции
CN101928331B (zh) * 2009-06-26 2014-05-28 上海来益生物药物研究开发中心有限责任公司 一种化合物及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2145609C1 (ru) * 1994-01-28 2000-02-20 Эли Лилли Энд Компани Производные гликопептида или их соли, способ получения, фармацевтическая композиция

Also Published As

Publication number Publication date
NZ502762A (en) 2001-10-26
EP0897725A3 (en) 2000-02-09
ES2229454T3 (es) 2005-04-16
NO327042B1 (no) 2009-04-06
PT897725E (pt) 2004-12-31
IL134597A (en) 2007-09-20
UA59410C2 (uk) 2003-09-15
NO20000851L (no) 2000-02-21
CZ299098B6 (cs) 2008-04-23
US5994297A (en) 1999-11-30
DK0897725T3 (da) 2004-12-13
WO1999010006A1 (en) 1999-03-04
DE69826795D1 (de) 2004-11-11
HUP0002920A3 (en) 2001-12-28
CN1276728A (zh) 2000-12-13
ATE278413T1 (de) 2004-10-15
DE69826795T2 (de) 2005-10-06
HU226593B1 (en) 2009-04-28
EP0897725B1 (en) 2004-10-06
EA002602B1 (ru) 2002-06-27
NO20000851D0 (no) 2000-02-21
JP2001513573A (ja) 2001-09-04
EP0897725A2 (en) 1999-02-24
AU747418B2 (en) 2002-05-16
EA200000250A1 (ru) 2000-08-28
BR9811917A (pt) 2000-08-15
ID24908A (id) 2000-08-31
KR100589548B1 (ko) 2006-06-15
CZ2000619A3 (en) 2001-05-16
AU8913798A (en) 1999-03-16
CA2301589A1 (en) 1999-03-04
KR20010023108A (ko) 2001-03-26
HUP0002920A2 (hu) 2001-01-29
TR200000475T2 (tr) 2000-08-21

Similar Documents

Publication Publication Date Title
ES2139043T3 (es) Compuestos de azaciclohexapeptidos.
PA8432701A1 (es) Derivados triciclicos sustituidos con fenilamino.
HN2000000051A (es) Derivados heterociclicos utiles como agentes anticancerosos
EP1037650A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF STAPHYLOCOCCUS AUREUS INFECTIONS
IT1254564B (it) Anticoagulanti e processi per la loro preparazione
WO2003037259A3 (en) Methods for the prevention or treatment of bacterial and fungal infections
ES2110401T3 (es) Antibioticos pentapeptidicos derivados de dalbaheptidos.
FI924424A0 (fi) Hjaertskyddande tokoferolanaloger.
MX232591B (es) Procedimiento para tratar infecciones oculares con azitromicina
ES2136457T3 (es) Dimeros unidos covalentemente de antibioticos glucopeptidicos.
ES2140184T3 (es) Dimeros unidos covalentemente de antibioticos glicopeptidicos.
TNSN04035A1 (fr) Azithromycine en dose unique
EA200000407A1 (ru) Пептиды млекопитающих для лечения микробной инфекции
IL134597A0 (en) Therapy for staphylococcus aureus
FR2674539B1 (fr) Procede de preparation enzymatique de macrolactone.
EA200100701A1 (ru) Белки наружной поверхности, их гены и их применение
SE9001111D0 (sv) Supportive use
ECSP951463A (es) Compuestos biciclicos

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed